China Health P/FCF
What is the P/FCF of China Health?
The P/FCF of China Health Group Inc. is 25.98
What is the definition of P/FCF?
Price to free cash flow (P/FCF) is a valuation metric that compares the company’s current share price to its free cash flow per share.
ttm (trailing twelve months)
Price to free cash flow (P/FCF) is a measure that value investors find useful to analyze a company’s finances in relation to its current stock price. It is a stricter measure than the price to cash flow ratio as it subtracts capital expenditures from cash flow.
Free cash flow relies heavily on the state of a company's cash from operations, which is in turn heavily influenced by the company's net income. Companies can manipulate their free cash flow by lengthening the time they take to pay their bills, shortening the time it takes to collect what's owed to them, and putting off buying inventory. It also depends on what items are considered capital expenditures and this can be different in case of different companies.
Lower values of P/FCF generally indicate a company that is undervalued and whose stock is relatively cheap in relation to its free cash flow. Conversely, higher P/FCF indicate that the company's stock is relatively overvalued. Value investors thus favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.
It is best to compare price to free cash flow ratios between similar companies in the same industry. However, the P/FCF metric can also be viewed over a longer time frame to see if the company's cash flow to share price value is improving or declining.
P/FCF of companies in the Health Care sector on HKSE compared to China Health
What does China Health do?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Companies with p/fcf similar to China Health
- Relx Plc has P/FCF of 25.91
- BlackRock Massachusetts Tax-Exempt Trust has P/FCF of 25.92
- BlackRock Massachusetts Tax-Exempt Trust has P/FCF of 25.92
- Ayr Strategies has P/FCF of 25.93
- Office Properties Income Trust has P/FCF of 25.93
- JFrog Ltd has P/FCF of 25.96
- China Health has P/FCF of 25.98
- Marriott International has P/FCF of 26.01
- Sinotrans has P/FCF of 26.01
- Dun & Bradstreet has P/FCF of 26.03
- ReWorld Media SA has P/FCF of 26.03
- Advanced Medical Solutions Plc has P/FCF of 26.03
- The Original BARK has P/FCF of 26.03